Andrew Stober

Chief Manufacturing Officer @ Encoded Therapeutics arrow icon

About Andrew Stober

Andrew Stober is a seasoned manufacturing executive in the biotechnology sector, currently serving as the Chief Manufacturing Officer, with extensive experience in gene therapy manufacturing and supply chain operations.

Known information

Andrew Stober is a prominent figure in the biotechnology manufacturing industry, holding the position of Chief Manufacturing Officer. He has a rich background in the field, having previously served as Senior Vice President and Chief Technical Officer at Novartis, where he was responsible for overseeing gene therapy manufacturing, program management, engineering, and supply chain operations. His significant contributions include supporting the evolution of corporate manufacturing capabilities for the gene therapy portfolio at AveXis, guiding it from clinical development through to product launch. Prior to his roles at Novartis and AveXis, Stober held multiple senior manufacturing positions at Biogen, ultimately serving as Senior Director of Manufacturing. His early career involved various capacities at well-known companies such as Amgen and Merck & Co. Stober’s educational foundation is a B.S. in Chemical Engineering from Lehigh University, equipping him with the technical expertise required for his advanced roles in the industry.

About Encoded Therapeutics

Encoded Therapeutics focuses on developing precision gene therapies for pediatric central nervous system disorders, with its leading program, ETX101, targeting Dravet syndrome.

report flag Report inaccurate information

People similar to Andrew Stober

Kartik Ramamoorthi

Co-founder, Chief Executive Officer & Board Member @ Encoded Therapeutics

Kartik Ramamoorthi is the co-founder and CEO of a biotech company, known for his educational background in neuroscience from MIT and Rutgers University, and his recognition in multiple prestigious under-40 lists.

Stephanie Tagliatela

Co-founder, Chief Scientific Officer & Board Member @ Encoded Therapeutics

Stephanie Tagliatela is a co-founder, Chief Scientific Officer, and Board Member, recognized as one of the top 30 biotech leaders under 40 by Business Insider for her contributions to the field.

Sal Rico

Chief Medical Officer @ Encoded Therapeutics

Sal Rico is the Chief Medical Officer with a strong background in pharmacology and clinical development, known for leading the development of gene therapies and contributing to the regulatory approval of various medical products.

Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free